Evidence map›Paper›PMID 42565598›Full record

ArticlemSystems2026

Metabolic rewiring of bacterial subpopulations governs polymyxin responses in

Mei-Ling Han, Zhi Ying Kho, Xingjian Wang, Jinxin Zhao, Ben Finnin, Yan Zhu, Christopher K Barlow, Darren J Creek, Tony Velkov, Mohammad A K Azad and 1 more

Abstract read
In one paragraph

Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mei-Ling HanInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0002-0861-2437
Zhi Ying KhoInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Xingjian WangInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jinxin ZhaoInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Ben FinninCell Therapy Pty Ltd, Melbourne, Victoria, Australia.
Yan ZhuSystems Biology Centre, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.ORCID 0000-0001-7342-3782
Christopher K BarlowMonash Proteomics and Metabolomics Platform, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Darren J CreekMonash Proteomics and Metabolomics Platform, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-7497-7082
Tony VelkovDepartment of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Mohammad A K AzadInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jian LiInfection Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-7953-8230

Funding

Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’R01AI132154 · NIAID · MONASH UNIVERSITY · PI LI, JIAN, VELKOV, TONY · 2017 to 2021
$4.3M
Department of Education and Training | Australian Research Council (ARC) DP250102726, DE230100356Department of Education and Training | Australian Research Council (ARC) FT220100564Department of Education and Training | Australian Research Council (ARC) IM230100534National Health and Medical Research Council APP2025937National Institute of Allergy and Infectious Diseases R01 AI132154NIAID NIH HHS R01 AI132154
6 · The paper itself

Abstract

Polymyxins are often last-resort antibiotics against high-priority Gram-negative pathogens, particularly

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsPolymyxinsArginineFlow CytometryMetabolic ReprogrammingAnti-Bacterial AgentsArgininePolymyxinsAcinetobacter baumanniiarginine metabolismcell-sortingheteroresistancemetabolomicsPI stainingpolymyxins

Identifiers

PMID42565598
PMCPMC13595966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.